Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Lewis

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patientsJoost van der Hoek, Wouter W de Herder, Richard A Feelders, et al.
JCO Global Oncology|April 28, 2021
Trends in International Cancer Research Investment 2006-2018Rachel Abudu, Gauthier Bouche, Karima Bourougaa, et al.
BMJ Open Gastroenterology|January 20, 2022
Crohn's disease therapeutic dietary intervention (CD-TDI): study protocol for a randomised controlled trialMaitreyi Raman, Christopher Ma, Lorian M Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patientsMichael Paulussen, Alan W Craft, Ian Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trialMarie-Cécile Le Deley, Michael Paulussen, Ian Lewis, et al.
Cell Chemical Biology|January 10, 2023
Clearance of plasma PCSK9 via the asialoglycoprotein receptor mediated by heterobifunctional ligandsJeffrey T Bagdanoff, Thomas M Smith, Martin Allan, et al.
Internal Medicine Journal|June 20, 2017
Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapseAndrew B M Lim, Cameron Curley, Chun Y Fong, et al.
Blood|March 1, 2011
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphomaRichard L Piekarz, Robin Frye, H Miles Prince, et al.
Nature Communications|March 4, 2021
Staphylococcus aureus induces an itaconate-dominated immunometabolic response that drives biofilm formationKira L Tomlinson, Tania Wong Fok Lung, Felix Dach, et al.
MMWR. Morbidity and Mortality Weekly Report|September 27, 2019
Progress Toward Poliovirus Containment Implementation - Worldwide, 2018-2019Daphne B Moffett, Anna Llewellyn, Harpal Singh, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patientsJoost van der Hoek, Wouter W de Herder, Richard A Feelders, et al.
JCO Global Oncology|April 28, 2021
Trends in International Cancer Research Investment 2006-2018Rachel Abudu, Gauthier Bouche, Karima Bourougaa, et al.
BMJ Open Gastroenterology|January 20, 2022
Crohn's disease therapeutic dietary intervention (CD-TDI): study protocol for a randomised controlled trialMaitreyi Raman, Christopher Ma, Lorian M Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patientsMichael Paulussen, Alan W Craft, Ian Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trialMarie-Cécile Le Deley, Michael Paulussen, Ian Lewis, et al.
Cell Chemical Biology|January 10, 2023
Clearance of plasma PCSK9 via the asialoglycoprotein receptor mediated by heterobifunctional ligandsJeffrey T Bagdanoff, Thomas M Smith, Martin Allan, et al.
Internal Medicine Journal|June 20, 2017
Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapseAndrew B M Lim, Cameron Curley, Chun Y Fong, et al.
Blood|March 1, 2011
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphomaRichard L Piekarz, Robin Frye, H Miles Prince, et al.
Nature Communications|March 4, 2021
Staphylococcus aureus induces an itaconate-dominated immunometabolic response that drives biofilm formationKira L Tomlinson, Tania Wong Fok Lung, Felix Dach, et al.
MMWR. Morbidity and Mortality Weekly Report|September 27, 2019
Progress Toward Poliovirus Containment Implementation - Worldwide, 2018-2019Daphne B Moffett, Anna Llewellyn, Harpal Singh, et al.
Pageof 10